Infection Prevention Devices Market: Growing Antibiotic Resistance to Bolster Demand

Infection Prevention Devices Market: Proliferation of Antibiotic Resistance and Hospital-associated Infections to Propel Adoption

Modern patients have expressed their beliefs in prevention, rather than cure, in a bid to minimize healthcare expenses and boost overall health. Owing to this, most bioengineering efforts need to be directed to the level of prevention, thereby enhancing patient care. Another factor driving the need for the prevention of diseases and infections is antibiotic resistance, which is a globally-rising issue. Moreover, the slow-paced and complex development of new antibiotics is decreasing the healthcare sector’s arsenal of existing drugs, posing a severe threat as ordinary infections become difficult to treat.

Read Report Overview -

As the fight for endurance continues, infection prevention is becoming a vital aspect. With the escalating aggregation of antimicrobial resistance, the healthcare sector has to revert back to the very basics of infection control; develop, evaluate, and implement sets of prevention methods. Transparency Market Research (TMR), in its recent publication on the infection prevention devices market, uncovers the essentials of the industry, with focus on the indications showcasing developments in the market.

History Paves the Way for the Future

Scientific study of nosocomial or hospital cross-infection commenced in the early 18th century, followed by the start of the 'Bacteriological Era', which marked the development of new methods of investigating disease outbreaks. The actual understanding of hospital infection was with the discoveries of Pasteur, Koch, and Lister, along with the beginning of the Bacteriological Era. The 19th century seemed to herald the final victory over hospital cross-infection, and witnessed the successes of hospital asepsis and reform. However, this victory was momentary, as it was discovered that, the occurrence of infections was not only in surgical and obstetric patients but also in medical patients, and that air could be a source of infection. Followed by this, the causes of hospital infections along with antibiotic-resistant organisms garnered attention.

Request Brochure of Report -

Infection prevention and control evolved over time, bringing modern practices into the spotlight. Modern healthcare underwent significant transformations over the years, adopting a proactive approach over the conventionally in-practice, reactive approach. Infection prevention and control took a quantum leap with the emergence of infection control devices, further supported by continued developments and improvisations. The infection prevention devices market is expected to hold a value of ~ US$ 16.9 Bn in 2019, with gains banking on the increasing number of surgical procedures and growing incidents of chronic diseases.

Key Trends Impacting Market Growth

Rising Geriatric Population to Create Opportunities

The rising geriatric population and increasing incidences of chronic diseases among the older population are creating opportunities for infection prevention devices market players, as hospital admissions continue to rise. Combating hospital-associated infections is becoming a crucial part of patient care, directing attention towards next-gen infection prevention devices.

Request for Analysis of COVID-19 Impact on Infection Prevention Devices Market -

Growing Antibiotic Resistance to Bolster Demand

Although healthcare continues to develop, emerging organisms are becoming stronger and more immune to antibiotics. Antibiotic resistance is emerging as a global health issue. Alternative measures include innovative antibiotics, which would be expensive, or the usage of phage therapy. On account of this, infection prevention and control remains the most sought-after way to combat this health concern.

Evolving Hospital-level Care in Other Environments

The emergence of personalized patient care, and establishment of urgent care clinics and primary care clinics are reflecting the expansion of patient-care across hospital levels. Organizations following this path require infection prevention supplies and equipment to minimize or eradicate the spread of pathogens. The establishment of such mobile and efficient clinical care centers is likely to create major demand for infection prevention devices.

Infection prevention devices continue to gain momentum across a number of end uses, and the increasing number of surgeries continues to offer growth potential for this business. However, as the healthcare sector continues to develop, next-gen therapeutics and treatments are being provided to patients, resulting in reduced hospital stay, thereby minimizing the need for infection prevention devices. This could hinder the growth of the infection prevention devices market.

Request for Custom Research -

Success Strategies of Manufacturers

Leverage Ultraviolet Technology

With the rise in antibiotic-resistant bacteria and virulent viruses over the last couple of years, healthcare professionals are analyzing their infection prevention methods and adopting newer, improved alternatives that promote better methods of disinfection. One such technique is the ultraviolet infection prevention technology. A new study shows that, ultraviolet disinfection technology eliminates nearly 98 percent of pathogens in the operating room, and might also help defeat superbugs. The implementation of this technique in next-gen infection prevention devices would help providers gain greater margins in sales.

Introduce Advanced Products

Research and development remains a vital strategy for key infection prevention devices market players. Key investments are made for enhancing R&D capabilities in a bid to introduce newer and advanced products to gain a strong market position. Moreover, key research activities are being focused primarily on improving patient outcomes and minimizing failure rates in patients with infectious diseases.

Strengthen Distribution in the U.S.

North America has showcased major growth opportunities for the injection prevention devices market. Continued developments in healthcare and advancements in technologies that support enhanced patient care witnessed across the U.S. are creating major demand for infection prevention and control techniques. Strengthening distribution across North America could allow companies to churn greater profits.

Buy Infection Prevention Devices Market Report at

Analysis of the Competitive Landscape

In 2018, Coloplast A/S acquired IncoCare Gunhild Vieler GmbH, a German direct-to-consumer homecare company, to strengthen its position in Germany. Coloplast and IncoCare plan to bring innovative products and services to more consumers across the country.

In 2019, Hollister Incorporated launched the Infyna Chic intermittent catheter, the latest in its line of female hydrophilic catheter offerings. This new catheter is designed to help provide women who use catheters with a high level of discretion. This product would be added to the complete Infyna portfolio, offering women a variety of options to meet their individual needs.

Mölnlycke Health Care AB and Zuellig Pharma entered into a partnership to focus on offering advanced wound care products and solutions to healthcare practitioners and patients across Southeast Asia.

Companies operating in the infection prevention devices market continue to invest in research and development to offer end users with advanced infection prevention supplies. With the support of infection tracking software and AI-enabled systems, infection prevention devices market players are able to offer improved product capabilities. Collaborations and partnerships in a bid to expand both, product portfolio and distribution, are majorly considered.

Browse More Trending Reports by Transparency Market Research:

Neuromyelitis Optica Spectrum Disorder Market:

Halal and Kosher Empty Capsules Market:

Intrauterine Contraceptive Rings Market:

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453

Back to news